(R)-(+)-4-异丙基-5,5-二甲基-2-恶唑烷酮 | 223906-38-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 中文名称: (R)-(+)-4-异丙基-5,5-二甲基-2-恶唑烷酮
• 中文别名: (R)-(+)-4-异丙基-5,5-二甲基-2-噁唑烷酮
• 英文名称: (4R)-5,5-dimethyl-4-(propan-2-yl)-1,3-oxazolidin-2-one
• 英文别名: (4R)-5,5-Dimethyl-4-isopropyloxazolidin-2-one；(R)-4-isopropyl-5,5-dimethyloxazolidin-2-one；(R)-(+)-4-isopropyl-5,5-dimethyloxazolidin-2-one；(R)-(+)-4-Isopropyl-5,5-dimethyl-2-oxazolidinone；(4R)-5,5-dimethyl-4-propan-2-yl-1,3-oxazolidin-2-one
• CAS: 223906-38-5
• 化学式: C₈H₁₅NO₂
• 分子量: 157.213
• InChiKey: QICFUFOXXNIZFF-ZCFIWIBFSA-N

物化性质

• 熔点：
  86-87 °C(lit.)
• 沸点：
  284.2±7.0 °C(Predicted)
• 密度：
  0.965±0.06 g/cm3(Predicted)
• 闪点：
  68 °F
• 稳定性/保质期：

  远离氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  F,Xi
• 安全说明：
  S16,S26,S36
• 危险类别码：
  R36/37/38,R11
• 海关编码：
  2934999090
• WGK Germany：
  3
• 储存条件：
  存放在密封容器内，并置于阴凉、干燥处。储存地点需远离氧化剂、明火和高温。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : (R)-(+)-4-Isopropyl-5,5-dimethyl-2-oxazolidinone
CAS-No. : 223906-38-5

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Skin irritation (Category 2)
Eye irritation (Category 2)
Specific target organ toxicity - single exposure (Category 3)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Highly flammable. Irritating to eyes, respiratory system and skin.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Precautionary statement(s)
Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R11 Highly flammable.
R36/37/38 Irritating to eyes, respiratory system and skin.
S-phrase(s)
S16 Keep away from sources of ignition - No smoking.
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36 Wear suitable protective clothing.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C8H15NO2
Molecular Weight : 157,21 g/mol
Component Concentration
(R)-(+)-4-Isopropyl-5,5-dimethyl-2-oxazolidinone
CAS-No. 168297-86-7 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Impervious clothing., The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: white
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 86 - 87 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point 20 °C - closed cup
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine Pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (R)-(+)-4-异丙基-5,5-二甲基-2-恶唑烷酮 在 正丁基锂 、 ammonium cerium (IV) nitrate 、 三乙酰氧基硼氢化钠 、 碳酸氢钠 、 溶剂黄146 作用下， 以 四氢呋喃 、 乙醇 、 水 、 1,2-二氯乙烷 、 乙腈 为溶剂， 反应 86.0h， 生成
  参考文献：
  名称：

  海洋生物碱（-）-（S）-那金那汀C的不对称合成

  摘要：

  描述了海洋生物碱（-）-（S）-那金那丁C的第一个不对称合成。该合成方法是将二苄基酰胺锂共轭添加到N -α-苯基丙烯酰基SuperQuat衍生物中，然后使用2-吡啶酮作为引入立体化学的关键步骤，对中间烯醇化物进行非对映选择性质子化。通过9步从市场上可买到的atropic酸，98：2 dr [（Z : :（E）比率]和> 99％ee的条件下，以13％的产率分离出（-）-（S）-NakinadineC 。

  DOI：

  10.1016/j.tetlet.2013.09.043
• 作为产物：
  描述：

  D-缬氨酸 在 氯化亚砜 、 potassium tert-butylate 、 碳酸氢钠 、 magnesium 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 120.5h， 生成 (R)-(+)-4-异丙基-5,5-二甲基-2-恶唑烷酮
  参考文献：
  名称：

  Asymmetric alkylations using SuperQuat auxiliaries—an investigation into the synthesis and stability of enolates derived from 5,5-disubstituted oxazolidin-2-ones

  摘要：

  对多种N-酰基-5,5-二甲基噁唑啉-2-酮和N-酰基-5,5-二苯基噁唑啉-2-酮衍生的烯醇负离子的烷基化研究表明，当使用手性辅助剂4-异丙基-5,5-二甲基噁唑啉-2-酮时，可以获得高产率和高的立体选择性。

  DOI：

  10.1039/a809715a

文献信息

• Asymmetric Catalysis in Liquid Confinement: Probing the Performance of Novel Chiral Rhodium–Diene Complexes in Microemulsions and Conventional Solvents
  作者：Max Deimling、Manuel Kirchhof、Barbara Schwager、Yaseen Qawasmi、Alex Savin、Tina Mühlhäuser、Wolfgang Frey、Birgit Claasen、Angelika Baro、Thomas Sottmann、Sabine Laschat

  DOI：10.1002/chem.201900947

  日期：2019.7.17

  studied using the 1,2‐addition of phenylboroxine (2) to N‐tosylimine 1 in the presence of [RhCl(C2H4)2]2 and chiral diene ligands as benchmark reaction. To get access to Rh complexes of different polarity, enantiomerically pure C2‐symmetric p‐substituted 3,6‐diphenylbicyclo[3.3.0]octadienes 4 and diastereomerically enriched unsymmetric norbornadienes 5 and 6 carrying either the Evans or the SuperQuat

  在[RhCl（C 2 H 4）2 ] 2存在下，以手性二烯配体为基准，研究了液相限制在不对称Rh催化中的作用，方法是将1,2,2-苯基环硼氧烷（2）加到N- tosylimine 1中。反应。为了获得不同极性的Rh络合物，对映体纯C 2对称的对位取代3,6-二苯基双环[3.3.0]辛二烯4和非对映体富集的不对称降冰片二烯5和6合成了携带Evans或SuperQuat辅助工具的产品。使用亲水性糖表面活性剂正辛基β- d-吡喃葡萄糖苷（C 8 G 1）配制包含等量H 2 O / KOH和甲苯/反应物的微乳液，以调解非极性反应物与KOH之间的混溶性激活Rh-二烯配合物。这种有组织的反应介质的突出特点是对温度不敏感，并且存在水和富含甲苯的隔室，通过小角度X射线散射（SAXS）证实了其区域大小为55Å。尽管双环辛二烯配体4 a，b，e在均相和微乳液条件下同样表现良好，配体4 c，d给出了不同的化学选
• Fluorine in fragrances: exploring the difluoromethylene (CF₂) group as a conformational constraint in macrocyclic musk lactones
  作者：Michael J. Corr、Rodrigo A. Cormanich、Cortney N. von Hahmann、Michael Bühl、David B. Cordes、Alexandra M. Z. Slawin、David O'Hagan

  DOI：10.1039/c5ob02023a

  日期：——

  The synthesis of a series of selectively fluorinated musk lactones is reported with CF₂ groups at various locations to bias conformation the ring.

  报道了一系列有选择性氟化的麝香内酯的合成，其中在不同位置有CF₂基团以偏向构象环。
• (−)-(S)-Nakinadine B: first asymmetric synthesis
  作者：Stephen G. Davies、James A. Lee、Paul M. Roberts、Rushabh S. Shah、James E. Thomson

  DOI：10.1039/c2cc34808j

  日期：——

  (−)-(S)-Nakinadine B has been synthesized for the first time (in 9 steps and 17% overall yield from commercially available atropic acid) using the conjugate addition of lithium dibenzyl-amide to an N-α-phenylacryloyl SuperQuat derivative with in situ diastereoselective enolate protonation as the key step.

  (−)-(S)-Nakinadine B首次被合成（经过9步反应，整体产率为17%，以商业可得的阿托品酸为起始材料），该合成采用了将锂二苄基胺与N-α-苯基丙烯酰超季铵衍生物进行共轭加成的方式，其中原位的非对映选择性烯酸质子化是关键步骤。
• Chemical differentiation of three DMSP lyases from the marine Roseobacter group
  作者：Immo Burkhardt、Lukas Lauterbach、Nelson L. Brock、Jeroen S. Dickschat

  DOI：10.1039/c7ob00913e

  日期：——

  Dimethylsulfoniopropionate (DMSP) catabolism of marine bacteria plays an important role in marine and global ecology. The genome of Ruegeria pomeroyi DSS-3, a model organism from the Roseobacter group, harbours no less than three genes for different DMSP lyases (DddW, DddP and DddQ) that catalyse the degradation of DMSP to dimethyl sulfide (DMS) and acrylate. Despite their apparent similar function

  海洋细菌二甲基磺化丙酸酯（DMSP）分解代谢在海洋和全球生态中起着重要作用。卢氏菌群模型动物Ruegeria pomeroyi DSS-3的基因组中含有不少于三个不同DMSP裂解酶（DddW，DddP和DddQ）的基因，这些酶催化DMSP降解为二甲基硫醚（DMS）和丙烯酸酯。尽管它们具有明显的相似功能，但这些酶没有显示出明显的整体序列同一性。在这项工作中，来自R. pomeroyi的DddQ和DddW和来自Phieobacter inhibens的DddP同源物对DSM 17395进行了功能表征，并使用几种合成的DMSP类似物测试了其底物范围。对比动力学分析揭示了DMSP及其类似物在选择性和总速度方面的转化差异，从而使人们对DMSP裂解酶的分子机制及其推测的生物学功能有了更多的了解。
• C-9 ALKENYLIDINE BRIDGED MACROLIDES
  申请人：Phan Ly Tam

  公开号：US20080119418A1

  公开（公告）日：2008-05-22

  The present invention discloses compounds of formulae (I), (II) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

  本发明揭示了以下化合物的公式（I），（II）或其药学上可接受的盐，酯或前药：具有抗菌性质。本发明还涉及包括上述化合物的制药组合物，用于治疗需要抗生素治疗的受体。本发明还涉及通过给予包含本发明化合物的制药组合物来治疗受体的细菌感染的方法。本发明还包括制备本发明化合物的方法。